MyAverix Finance
LSE · Healthcare
N4 Pharma PLC (N4P)
Biotechnology
N4 Pharma PLC (N4P) is listed on LSE in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for N4P
N4 Pharma PLC (N4P) — FAQ
What is N4P's P/E ratio?
The price-to-earnings (P/E) ratio for N4 Pharma PLC (N4P) is 25.00 (data as of 2026-05-19).
Does N4 Pharma PLC pay a dividend?
Dividend yield is not available in the current snapshot for N4 Pharma PLC (N4P). Check the MyAverix Finance app for the latest dividend data.
What sector is N4 Pharma PLC in?
N4 Pharma PLC (N4P) is classified in the Healthcare sector (Biotechnology industry).
What exchange is N4P listed on?
N4P is listed on LSE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.